Search research articles
Contact Us
Filters
Showing results (111-120 of 174) with videos related to
Page
of 18
Sort By:
The Biochemical Journal
|
June 24, 2018
New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors
Dominic P Byrne, Yong Li, Pawin Ngamlert, et al.
Chemmedchem
|
April 11, 2022
Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype
Christopher R M Asquith, Louisa Temme, Michael P East, et al.
Journal of Medicinal Chemistry
|
April 12, 2019
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma
Christopher R M Asquith, Kaleb M Naegeli, Michael P East, et al.
Plos One
|
August 4, 2017
Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes
Margarite D Matossian, Steven Elliott, Van T Hoang, et al.
ACS Chemical Biology
|
December 24, 2015
Discovery of Novel Small Molecules that Activate Satellite Cell Proliferation and Enhance Repair of Damaged Muscle
Andrew N Billin, Marcus Bantscheff, Gerard Drewes, et al.
Plant Direct
|
November 30, 2022
An open source plant kinase chemogenomics set
Maria Florencia Ercoli, Priscila Zonzini Ramos, Rashmi Jain, et al.
The Journal of Experimental Medicine
|
August 4, 1997
Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele
L Furci, G Scarlatti, S Burastero, et al.
Science Signaling
|
September 27, 2018
Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells
Daniel M Foulkes, Dominic P Byrne, Wayland Yeung, et al.
Scientific Reports
|
December 19, 2022
In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer
Ayele H Negussie, Andrew S Mikhail, Joshua W Owen, et al.
The EMBO Journal
|
August 20, 2019
E2F1 proteolysis via SCF-cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition
Kamila Burdova, Hongbin Yang, Roberta Faedda, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 174) with videos related to
Sort By:
Page
of 18
The Biochemical Journal
|
June 24, 2018
New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors
Dominic P Byrne, Yong Li, Pawin Ngamlert, et al.
Chemmedchem
|
April 11, 2022
Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype
Christopher R M Asquith, Louisa Temme, Michael P East, et al.
Journal of Medicinal Chemistry
|
April 12, 2019
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma
Christopher R M Asquith, Kaleb M Naegeli, Michael P East, et al.
Plos One
|
August 4, 2017
Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes
Margarite D Matossian, Steven Elliott, Van T Hoang, et al.
ACS Chemical Biology
|
December 24, 2015
Discovery of Novel Small Molecules that Activate Satellite Cell Proliferation and Enhance Repair of Damaged Muscle
Andrew N Billin, Marcus Bantscheff, Gerard Drewes, et al.
Plant Direct
|
November 30, 2022
An open source plant kinase chemogenomics set
Maria Florencia Ercoli, Priscila Zonzini Ramos, Rashmi Jain, et al.
The Journal of Experimental Medicine
|
August 4, 1997
Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele
L Furci, G Scarlatti, S Burastero, et al.
Science Signaling
|
September 27, 2018
Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells
Daniel M Foulkes, Dominic P Byrne, Wayland Yeung, et al.
Scientific Reports
|
December 19, 2022
In vitro characterization of immune modulating drug-eluting immunobeads towards transarterial embolization in cancer
Ayele H Negussie, Andrew S Mikhail, Joshua W Owen, et al.
The EMBO Journal
|
August 20, 2019
E2F1 proteolysis via SCF-cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition
Kamila Burdova, Hongbin Yang, Roberta Faedda, et al.
Page
of 18